![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | increases expression | ISO | RGD:11503 | 6480464 | 1-Methyl-4-phenyl-1 more ... | CTD | PMID:20230807 | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:11503 | 6480464 | [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... | CTD | PMID:20230807 | 17beta-estradiol | decreases expression | ISO | RGD:737536 | 6480464 | Estradiol results in decreased expression of MAP3K12 mRNA | CTD | PMID:31614463 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MAP3K12 mRNA | CTD | PMID:21215274 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:11503 | 6480464 | Tetrachlorodibenzodioxin affects the expression of MAP3K12 mRNA | CTD | PMID:21570461 | 2-ethoxyethanol | decreases expression | EXP | | 6480464 | 2-ethoxyethanol results in decreased expression of MAP3K12 mRNA | CTD | PMID:19643169 | 2-methoxyethanol | decreases expression | EXP | | 6480464 | methyl cellosolve results in decreased expression of MAP3K12 mRNA | CTD | PMID:19643169 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:737536 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAP3K12 mRNA | CTD | PMID:28628672 | 3H-1,2-dithiole-3-thione | increases expression | EXP | | 6480464 | 1, 2-dithiol-3-thione results in increased expression of MAP3K12 mRNA | CTD | PMID:19162173 | 4-tert-Octylphenol | increases expression | EXP | | 6480464 | 4-tert-octylphenol results in increased expression of MAP3K12 mRNA | CTD | PMID:17011747 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of MAP3K12 mRNA | CTD | PMID:30047161 | aflatoxin B1 | increases expression | ISO | RGD:737536 | 6480464 | Aflatoxin B1 results in increased expression of MAP3K12 mRNA | CTD | PMID:21641981 | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of MAP3K12 mRNA | CTD | PMID:30047161 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of MAP3K12 mRNA | CTD | PMID:16483693 | amosite asbestos | decreases methylation | ISO | RGD:737536 | 6480464 | Asbestos, Amosite results in decreased methylation of MAP3K12 promoter | CTD | PMID:29626692 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of MAP3K12 mRNA | CTD | PMID:30779732 | atrazine | increases expression | ISO | RGD:737536 | 6480464 | Atrazine results in increased expression of MAP3K12 mRNA | CTD | PMID:18585445 | benzo[a]pyrene | increases expression | ISO | RGD:737536 | 6480464 | Benzo(a)pyrene results in increased expression of MAP3K12 mRNA | CTD | PMID:19152381 | benzo[a]pyrene | decreases methylation | ISO | RGD:737536 | 6480464 | Benzo(a)pyrene results in decreased methylation of MAP3K12 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | multiple interactions | ISO | RGD:737536 | 6480464 | chlorophyllin inhibits the reaction [Benzo(a)pyrene results in increased expression of MAP3K12 mRNA] | CTD | PMID:19152381 | bexarotene | increases expression | EXP | | 6480464 | bexarotene results in increased expression of MAP3K12 mRNA | CTD | PMID:16648578 | bis(2-chloroethyl) sulfide | decreases expression | ISO | RGD:11503 | 6480464 | Mustard Gas results in decreased expression of MAP3K12 mRNA | CTD | PMID:15674843 | bisphenol A | increases expression | ISO | RGD:737536 | 6480464 | bisphenol A results in increased expression of MAP3K12 mRNA | CTD | PMID:25143472, PMID:29275510 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MAP3K12 mRNA | CTD | PMID:25181051 more ... | bisphenol F | multiple interactions | ISO | RGD:737536 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAP3K12 mRNA | CTD | PMID:28628672 | cadmium dichloride | multiple interactions | ISO | RGD:11503 | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of MAP3K12 mRNA | CTD | PMID:19840844 | caffeine | multiple interactions | ISO | RGD:11503 | 6480464 | [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... | CTD | PMID:20230807 | carboplatin | decreases expression | EXP | | 6480464 | Carboplatin results in decreased expression of MAP3K12 mRNA | CTD | PMID:18172885 | cefaloridine | decreases expression | EXP | | 6480464 | Cephaloridine results in decreased expression of MAP3K12 mRNA | CTD | PMID:18172885 | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of MAP3K12 mRNA | CTD | PMID:18172885 | cisplatin | increases expression | ISO | RGD:737536 | 6480464 | Cisplatin results in increased expression of MAP3K12 mRNA | CTD | PMID:27392435 | cisplatin | multiple interactions | ISO | RGD:737536 | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of MAP3K12 mRNA | CTD | PMID:27392435 | clozapine | increases expression | EXP | | 6480464 | Clozapine results in increased expression of MAP3K12 mRNA | CTD | PMID:15860345 | copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of MAP3K12 mRNA | CTD | PMID:30556269 | copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of MAP3K12 mRNA | CTD | PMID:30556269 | crocidolite asbestos | decreases methylation | ISO | RGD:737536 | 6480464 | Asbestos, Crocidolite results in decreased methylation of MAP3K12 promoter | CTD | PMID:29626692 | cyclophosphamide | affects expression | EXP | | 6480464 | Cyclophosphamide affects the expression of MAP3K12 mRNA | CTD | PMID:18246545 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of MAP3K12 mRNA | CTD | PMID:18172885 | dexamethasone | multiple interactions | ISO | RGD:737536 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAP3K12 mRNA | CTD | PMID:28628672 | diclofenac | decreases expression | EXP | | 6480464 | Diclofenac results in decreased expression of MAP3K12 mRNA | CTD | PMID:18172885 | diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of MAP3K12 mRNA | CTD | PMID:17011747 | dimethylarsinic acid | decreases expression | ISO | RGD:11503 | 6480464 | Cacodylic Acid results in decreased expression of MAP3K12 mRNA | CTD | PMID:17441966 | dorsomorphin | multiple interactions | ISO | RGD:737536 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP3K12 mRNA | CTD | PMID:27188386 | doxorubicin | increases expression | ISO | RGD:737536 | 6480464 | Doxorubicin results in increased expression of MAP3K12 mRNA | CTD | PMID:29803840 | ethyl methanesulfonate | increases expression | ISO | RGD:737536 | 6480464 | Ethyl Methanesulfonate results in increased expression of MAP3K12 mRNA | CTD | PMID:23649840 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of MAP3K12 mRNA | CTD | PMID:24136188 | formaldehyde | increases expression | ISO | RGD:737536 | 6480464 | Formaldehyde results in increased expression of MAP3K12 mRNA | CTD | PMID:23649840 | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of MAP3K12 gene | CTD | PMID:22079235 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of MAP3K12 mRNA | CTD | PMID:22061828 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of MAP3K12 mRNA | CTD | PMID:18172885 | haloperidol | increases expression | EXP | | 6480464 | Haloperidol results in increased expression of MAP3K12 mRNA | CTD | PMID:15860345 | indometacin | multiple interactions | ISO | RGD:737536 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAP3K12 mRNA | CTD | PMID:28628672 | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of MAP3K12 mRNA | CTD | PMID:30047161 | methyl methanesulfonate | increases expression | ISO | RGD:737536 | 6480464 | Methyl Methanesulfonate results in increased expression of MAP3K12 mRNA | CTD | PMID:23649840 | N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | RGD:11503 | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of MAP3K12 mRNA more ... | CTD | PMID:19840844 | nitrofen | decreases expression | EXP | | 6480464 | nitrofen results in decreased expression of MAP3K12 mRNA | CTD | PMID:33484710 | okadaic acid | multiple interactions | ISO | RGD:11503 | 6480464 | [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of MAP3K12 mRNA | CTD | PMID:19840844 | p-tert-Amylphenol | increases expression | EXP | | 6480464 | 4-tert-octylphenol results in increased expression of MAP3K12 mRNA | CTD | PMID:17011747 | paracetamol | increases expression | ISO | RGD:737536 | 6480464 | Acetaminophen results in increased expression of MAP3K12 mRNA | CTD | PMID:22230336 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MAP3K12 mRNA | CTD | PMID:33387578 | phenobarbital | affects expression | ISO | RGD:11503 | 6480464 | Phenobarbital affects the expression of MAP3K12 mRNA | CTD | PMID:23091169 | phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of MAP3K12 mRNA | CTD | PMID:30047161 | phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:11503 | 6480464 | [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of MAP3K12 mRNA | CTD | PMID:19840844 | propiconazole | decreases expression | ISO | RGD:11503 | 6480464 | propiconazole results in decreased expression of MAP3K12 mRNA | CTD | PMID:21278054 | quercetin | decreases expression | ISO | RGD:737536 | 6480464 | Quercetin results in decreased expression of MAP3K12 mRNA | CTD | PMID:15309432 | SB 431542 | multiple interactions | ISO | RGD:737536 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP3K12 mRNA | CTD | PMID:27188386 | serpentine asbestos | decreases methylation | ISO | RGD:737536 | 6480464 | Asbestos, Serpentine results in decreased methylation of MAP3K12 promoter | CTD | PMID:29626692 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of MAP3K12 mRNA | CTD | PMID:19281266 | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of MAP3K12 mRNA | CTD | PMID:30047161 | sulforaphane | decreases expression | ISO | RGD:737536 | 6480464 | sulforaphane results in decreased expression of MAP3K12 mRNA | CTD | PMID:31838189 | sunitinib | decreases expression | ISO | RGD:737536 | 6480464 | Sunitinib results in decreased expression of MAP3K12 mRNA | CTD | PMID:31533062 | temozolomide | increases expression | ISO | RGD:737536 | 6480464 | Temozolomide results in increased expression of MAP3K12 mRNA | CTD | PMID:31758290 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of MAP3K12 mRNA | CTD | PMID:23411599 | triptonide | affects expression | ISO | RGD:11503 | 6480464 | triptonide affects the expression of MAP3K12 mRNA | CTD | PMID:33045310 | triticonazole | decreases expression | EXP | | 6480464 | triticonazole results in decreased expression of MAP3K12 mRNA | CTD | PMID:36084822 | urethane | increases expression | ISO | RGD:737536 | 6480464 | Urethane results in increased expression of MAP3K12 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | ISO | RGD:737536 | 6480464 | Valproic Acid results in decreased expression of MAP3K12 mRNA | CTD | PMID:26272509 | valproic acid | multiple interactions | ISO | RGD:737536 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP3K12 mRNA | CTD | PMID:27188386 | vorinostat | decreases expression | ISO | RGD:737536 | 6480464 | vorinostat results in decreased expression of MAP3K12 mRNA | CTD | PMID:27188386 | zinc atom | increases expression | ISO | RGD:737536 | 6480464 | Zinc results in increased expression of MAP3K12 mRNA | CTD | PMID:19071009 | zinc(0) | increases expression | ISO | RGD:737536 | 6480464 | Zinc results in increased expression of MAP3K12 mRNA | CTD | PMID:19071009 | |